Correlates of Health-related Quality of Life in Type 2 Diabetes

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2006 Jun 6

PMID 16752167

Citations 119

Authors

D J Wexler

R W Grant

E Wittenberg

J L Bosch

E Cagliero

L Delahanty

M A Blais

J B Meigs

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: We assessed the impact of medical comorbidities, depression, and treatment intensity on quality of life in a large primary care cohort of patients with type 2 diabetes.

Methods: We used the Health Utilities Index-III, an instrument that measures health-related quality of life based on community preferences in units of health utility (scaled from 0=death to 1.0=perfect health), in 909 primary care patients with type 2 diabetes. Demographic and clinical correlates of health-related quality of life were assessed.

Results: The median health utility score for this population was 0.70 (interquartile range 0.39-0.88). In univariate analyses, older age, female sex, low socioeconomic status, cardiovascular disease, microvascular complications, congestive heart failure, peripheral vascular disease, chronic lung disease, depression, insulin use and number of medications correlated with decreased quality of life, while obesity, hypertension and hypercholesterolaemia did not. In multiple regression analyses, microvascular complications, heart failure and depression were most strongly related to decreased health-related quality of life, independently of duration of diabetes; in these models, diabetes patients with depression had a utility of 0.59, while patients without symptomatic comorbidities did not have a significantly reduced quality of life. Treatment intensity remained a significant negative correlate of quality of life in multivariable models.

Conclusions/interpretation: Patients with type 2 diabetes have a substantially decreased quality of life in association with symptomatic complications. The data suggest that treatment of depression and prevention of complications have the greatest potential to improve health-related quality of life in type 2 diabetes.

Citing Articles

The value of diabetes technology enabled coaching (DTEC) to support remission evaluation of medical interventions in T2D: Patient and health coach perspectives.

Taylor M, Ng D, Pfisterer K, Cafazzo J, Sherifali D PLOS Digit Health. 2025; 4(1):e0000701.

PMID: 39787052 PMC: 11717255. DOI: 10.1371/journal.pdig.0000701.

Impairment of health-related quality of life among people with type 2 diabetes and advanced liver fibrosis.

Michel M, Funuyet-Salas J, Doll M, Alqahtani S, Armandi A, Labenz C Sci Rep. 2024; 14(1):21650.

PMID: 39289410 PMC: 11408596. DOI: 10.1038/s41598-024-72105-8.

Health state utility values of type 2 diabetes mellitus and related complications: a systematic review and meta-regression.

Wang Y, Xu Y, Shan H, Pan H, Chen J, Yang J Health Qual Life Outcomes. 2024; 22(1):74.

PMID: 39244536 PMC: 11380328. DOI: 10.1186/s12955-024-02288-1.

Efficacy of Daily Walking as a Potential Predictor of Improved Health-Related Quality of Life in Patients with Type 2 Diabetes in Korea.

Park W, Lee D Healthcare (Basel). 2024; 12(16).

PMID: 39201202 PMC: 11353364. DOI: 10.3390/healthcare12161644.

Predictive Factors for Altered Quality of Life in Patients with Type 2 Diabetes Mellitus.

Albai O, Braha A, Timar B, Timar R J Clin Med. 2024; 13(15).

PMID: 39124656 PMC: 11313388. DOI: 10.3390/jcm13154389.

References

Kilbourne A, Reynolds 3rd C, Good C, Sereika S, Justice A, Fine M . How does depression influence diabetes medication adherence in older patients?. Am J Geriatr Psychiatry. 2005; 13(3):202-10. DOI: 10.1176/appi.ajgp.13.3.202. View

Baer L, JACOBS D, Blais M, Fava M, Kessler R, Magruder K . Development of a brief screening instrument: the HANDS. Psychother Psychosom. 1999; 69(1):35-41. DOI: 10.1159/000012364. View

. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group. Diabetes Care. 1999; 22(7):1125-36. DOI: 10.2337/diacare.22.7.1125. View

Grootendorst P, Feeny D, Furlong W . Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey. Med Care. 2000; 38(3):290-9. DOI: 10.1097/00005650-200003000-00006. View

Bourdel-Marchasson I, Dubroca B, Manciet G, Decamps A, Emeriau J, Dartigues J . Prevalence of diabetes and effect on quality of life in older French living in the community: the PAQUID Epidemiological Survey. J Am Geriatr Soc. 1997; 45(3):295-301. DOI: 10.1111/j.1532-5415.1997.tb00943.x. View

Coffey J, Brandle M, Zhou H, Marriott D, Burke R, Tabaei B . Valuing health-related quality of life in diabetes. Diabetes Care. 2002; 25(12):2238-43. DOI: 10.2337/diacare.25.12.2238. View

Maddigan S, Feeny D, Johnson J . A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes. Med Decis Making. 2003; 23(6):489-501. DOI: 10.1177/0272989X03258438. View

Manuel D, Schultz S . Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996-1997. Diabetes Care. 2004; 27(2):407-14. DOI: 10.2337/diacare.27.2.407. View

Ruo B, Rumsfeld J, Hlatky M, Liu H, Browner W, Whooley M . Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA. 2003; 290(2):215-21. PMC: 2776689. DOI: 10.1001/jama.290.2.215. View

10.

Brazier J, Deverill M, Green C, Harper R, Booth A . A review of the use of health status measures in economic evaluation. Health Technol Assess. 1999; 3(9):i-iv, 1-164. View

11.

Wells K, Sherbourne C . Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Arch Gen Psychiatry. 1999; 56(10):897-904. DOI: 10.1001/archpsyc.56.10.897. View

12.

Redekop W, Koopmanschap M, Stolk R, Rutten G, Wolffenbuttel B, Niessen L . Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002; 25(3):458-63. DOI: 10.2337/diacare.25.3.458. View

13.

Goldney R, Phillips P, Fisher L, Wilson D . Diabetes, depression, and quality of life: a population study. Diabetes Care. 2004; 27(5):1066-70. DOI: 10.2337/diacare.27.5.1066. View

14.

Naeim A, Keeler E, Mangione C . Options for handling missing data in the Health Utilities Index Mark 3. Med Decis Making. 2005; 25(2):186-98. DOI: 10.1177/0272989X05275153. View

15.

Revicki D, Wood M . Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications. J Affect Disord. 1998; 48(1):25-36. DOI: 10.1016/s0165-0327(97)00117-1. View

16.

Feeny D, Furlong W, Torrance G, Goldsmith C, Zhu Z, DePauw S . Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002; 40(2):113-28. DOI: 10.1097/00005650-200202000-00006. View

17.

Vijan S, Hayward R, Ronis D, Hofer T . Brief report: the burden of diabetes therapy: implications for the design of effective patient-centered treatment regimens. J Gen Intern Med. 2005; 20(5):479-82. PMC: 1490106. DOI: 10.1111/j.1525-1497.2005.0117.x. View

18.

Kopec J, Williams J, To T, Austin P . Measuring population health: correlates of the Health Utilities Index among English and French Canadians. Can J Public Health. 2001; 91(6):465-70. PMC: 6979995. View

19.

Maddigan S, Feeny D, Johnson J . Construct validity of the RAND-12 and Health Utilities Index Mark 2 and 3 in type 2 diabetes. Qual Life Res. 2004; 13(2):435-48. DOI: 10.1023/B:QURE.0000018497.06539.8f. View

20.

Jacobson A, de Groot M, Samson J . The effects of psychiatric disorders and symptoms on quality of life in patients with type I and type II diabetes mellitus. Qual Life Res. 1997; 6(1):11-20. DOI: 10.1023/a:1026487509852. View